Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine-Reference-Cited by-同舟云学术

Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine

Published:1985-01 Issue:10 Volume:9 Page:1255-1261
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Irle Claude,Joachim Deeg H.,Buckner C.Dean,Kennedy Michael,Clift Reginald,Storb Rainer,Appelbaum Frederick R.,Beatty Patrick,Bensinger William,Doney Kristine,Cheever Martin,Fefer Alexander,Greenberg Philip,Hill Roger,Martin Paul,McGuffin Robert,Sanders Jean,Stewart Patricia,Sullivan Keith,Witherspoon Robert,Thomas E.Donnall

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference30 articles.

1. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse;Appelbaum;Blood,1983

2. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation;Atkinson;Tranplantation,1984

3. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes;Atkinson;Br. J. Haemat.,1983

4. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation;Atkinson;Br. J. Haemat.,1983

5. Allogeneic marrow transplantation for acute leukemia in relapse;Badger;Leukemia Res.,1982

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EXABS-128-CT GVHD Prevention: What is the New Standard?;Clinical Lymphoma Myeloma and Leukemia;2023-09

2. Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation;Journal of Clinical Oncology;2021-02-10

3. Neurologic complications after allogeneic transplantation: a meta‐analysis;Annals of Clinical and Translational Neurology;2019-09-27

4. Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis;Expert Review of Hematology;2014-04-04

5. Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT;Bone Marrow Transplantation;2012-05-21